β-Lactams against tuberculosis \- New trick for an old dog?

New England Journal of Medicine

Volumn 375, Issue 4, 2016, Pages 393-394

  Diacon, Andreas H ^a   Van Der Merwe, Lize ^b   Barnard, Marinus ^b   Von Groote Bidlingmaier, Florian ^b   Lange, Christoph ^c   García Basteiro, Alberto L ^d   Sevene, Esperança ^e   Ballell, Lluís ^f   Barros Aguirre, David ^f  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b TASK APPLIED SCIENCE   (South Africa)

^c RESEARCH CENTER BORSTEL   (Germany)

^d CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^e Manhiça Health Research Center   (Mozambique)

^f GLAXOSMITHKLINE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIRETROVIRUS AGENT; BETA LACTAM DERIVATIVE; BETA LACTAMASE; ETHAMBUTOL; ISONIAZID; MEROPENEM; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TUBERCULOSTATIC AGENT; BETA LACTAM; BETA LACTAMASE INHIBITOR;

ANTIBIOTIC RESISTANCE; CLINICAL PRACTICE; COLONY FORMING UNIT; DRUG EFFICACY; DRUG SAFETY; GENETIC CODE; HUMAN; LETTER; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; SPUTUM ANALYSIS; TREATMENT RESPONSE; TUBERCULOSIS; UNSPECIFIED SIDE EFFECT; BACTERIAL COUNT; DRUG DEVELOPMENT; TUBERCULOSIS, MULTIDRUG-RESISTANT;

AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTITUBERCULAR AGENTS; BETA-LACTAMASE INHIBITORS; BETA-LACTAMS; COLONY COUNT, MICROBIAL; DRUG DISCOVERY; HUMANS; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84979894075     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1513236     Document Type: Letter

References (5)

1. Global tuberculosis report 2013. Geneva: World Health Organization, 2013 (http://apps.who.int/iris/bitstream/10665/91355/1/ 9789241564656-eng.pdf).
2. Tiemersma EW, van der Werf MJ, Borgdorff MW, Williams BG, Nagelkerke NJ. Natural history of tuberculosis: duration and fatality of untreated pulmonary tuberculosis in HIV negative patients: a systematic review. PLoS One 2011; 6(4): e17601.
3. Chambers HF, Kocagöz T, Sipit T, Turner J, Hopewell PC. Activity of amoxicillin/clavulanate in patients with tuberculosis. Clin Infect Dis 1998; 26: 874-7.
4. Donald PR, Sirgel FA, Venter A, et al. Early bactericidal activity of amoxicillin in combination with clavulanic acid in patients with sputum smear-positive pulmonary tuberculosis. Scand J Infect Dis 2001;33:466-9.
5. Hugonnet JE, Tremblay LW, Boshoff HI, Barry CE III, Blanchard JS. Meropenem-clavulanate is effective against extensively drug-resistant Mycobacterium tuberculosis. Science 2009; 323: 1215-8.